OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comprehensive comparison of DNA and RNA vaccines
Chunxi Wang, Fan Yuan
Advanced Drug Delivery Reviews (2024) Vol. 210, pp. 115340-115340
Closed Access | Times Cited: 20

Showing 20 citing articles:

Risk management of the vaccine supply chain: Interactions of risk factors and control strategies
M.F. Yang, Shaojian Qu, Ying Ji, et al.
Socio-Economic Planning Sciences (2025) Vol. 98, pp. 102153-102153
Closed Access | Times Cited: 2

Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6

Galectin-8 and GEL01 as Potential Adjuvants to Enhance the Immune Response Induced by a DNA Vaccine against Bovine Alphaherpesvirus Type-1
Claudia Alejandra Kornuta, Juan Esteban Bidart, Ivana Soria, et al.
Virology (2025) Vol. 604, pp. 110402-110402
Closed Access

Pseudomonas aeruginosa Vaccine Development: Lessons, Challenges, and Future Innovations
Rebeca Santamarina-Fernández, Víctor Fuentes-Valverde, Alis Silva-Rodríguez, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2012-2012
Open Access

Peptides: Potential Delivery Systems for mRNA
Huiting Liang, Yun Xing, Kai Wang, et al.
RSC Chemical Biology (2025)
Open Access

From protein to immunology: comprehensive insights into Marburg virus vaccines, mechanism, and application
Mohamed J. Saadh, Faris Anad Muhammad, Rafid Jihad Albadr, et al.
Archives of Microbiology (2025) Vol. 207, Iss. 4
Closed Access

Lipid-based nanoparticles for nucleic acids delivery
Sonia Sarnelli, Michael Cardamone, Ernesto Reverchon, et al.
Physical Sciences Reviews (2025)
Closed Access

Plattformtechnologien in der Impfstoffentwicklung
Eberhard Hildt
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2025)
Open Access

Development of a messenger RNA vaccine using pH-responsive dipeptide-conjugated lipids exhibiting reduced inflammatory properties
Katsuki Matayoshi, Sayaka Takahashi, Sung Ho Ryu, et al.
International Journal of Pharmaceutics (2025), pp. 125485-125485
Closed Access

Neoantigen vaccines: advancing personalized cancer immunotherapy
Alaa A. A. Aljabali, Yassmen Hamzat, Alaa Alqudah, et al.
Exploration of Immunology (2025) Vol. 5
Open Access

Vaccination and personalized cancer vaccines focusing on common cancers in women: a narrative review
Seyed Sadeq Mousavi Ghahfarrokhi, Pegah Karimi, Fateme-Sadat Mahdigholi, et al.
Pathology - Research and Practice (2025) Vol. 270, pp. 155983-155983
Closed Access

Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens
Wei-Yu Chi, Yingying Hu, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2024) Vol. 31, Iss. 1
Open Access | Times Cited: 2

Vaccines for cancer prevention: exploring opportunities and navigating challenges
Michele Graciotti, Lana E. Kandalaft
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 1

Spatiotemporal Control of Immune Responses with Nucleic Acid Cocktail Vaccine
Chunxi Wang, Andrew N. Macintyre, Thomas H. Oguin, et al.
Advanced Therapeutics (2024) Vol. 7, Iss. 11
Closed Access

Replication of the Venezuelan Equine Encephalitis Vaccine from a Synthetic PCR Fragment
Christine Mathew, Colin Tucker, Irina Tretyakova, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1217-1217
Open Access

DNA and mRNA vaccines: Significant therapeutic approach against cancer management
Aniruddha Sen, Vijay Singh, Sumel Ashique, et al.
Advances in immunology (2024)
Closed Access

mRNA Vaccines Against COVID-19 as Trailblazers for Other Human Infectious Diseases
Rossella Brandi, Alessia Paganelli, Raffaele D’Amelio, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1418-1418
Open Access

Pichia pastoris-Derived β-Glucan Capsules as a Delivery System for DNA Vaccines
Samara Sousa de Pinho, Maria da Conceição Viana Invenção, Anna Jéssica Duarte Silva, et al.
Vaccines (2024) Vol. 12, Iss. 12, pp. 1428-1428
Open Access

Page 1

Scroll to top